Brief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
15/10/2026 07:06
BRIEF-Oryzon Gets New Patent Grants For Vafidemstat In Four Countries Oct 15 (Reuters) - Oryzon Genomics SA ORY.MC:
RECEIVES NEW PATENT GRANTS FOR VAFIDEMSTAT IN FOUR COUNTRIES
GRANTED PATENTS FOR VAFIDEMSTAT IN BPD IN KOREA AND PHILIPPINES
GRANTED NEW ZEALAND PATENT FOR VAFIDEMSTAT IN AGGRESSION AND SOCIAL WITHDRAWAL
GRANTED MEXICAN PATENT FOR VAFIDEMSTAT IN AUTISM SPECTRUM DISORDER
VAFIDEMSTAT U.S. PATENT VALID UNTIL AT LEAST 2043, NON-U.S. PATENTS VALID UNTIL 2040
Source text: https://tinyurl.com/ycy2bm8k
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28